Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILLUMINATE
2024-510614-33-00Phase 2Authorised
- Sponsor
- University of Bonn
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in ovarian cancer, sponsored by University of Bonn. Planned start Jun 2025; status: authorised.
02
Drugs
5-aminolevulinic acid
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2024-510614-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510614-33-00.